Regulation detail

F-Tag F698

Up to date
Ask Ariadne
SR
F-Tag F698 active

§483.25(l) Dialysis.

Jurisdiction: CM Agency: Centers for Medicare & Medicaid Services
SNF (100%)
Plain-English summary

This federal regulation (F-Tag F698) governs nursing home (long-term care facility) obligations when residents require dialysis services, including hemodialysis and peritoneal dialysis. Operators must ensure dialysis is provided consistent with professional standards, coordinate care and communication with Medicare-certified dialysis facilities, maintain qualified and trained staff, develop dialysis-specific policies and procedures, and monitor residents before, during, and after treatments. The regulation does not govern dialysis facilities themselves, but rather the nursing home's responsibilities in arranging, coordinating, and (where applicable) directly providing dialysis care to its residents.

View official source
Regulation text
F698
(Rev. 229; Issued: 04-25-25; Effective: 04-25-25; Implementation: 04-28-25) 
 
§483.25(l) Dialysis. 
 
The facility must ensure that residents who require dialysis receive such services, 
consistent with professional standards of practice, the comprehensive person-
centered care plan, and the residents’ goals and preferences. 
 
INTENT: §483.25(l) 
 
The intent of this requirement is that the facility assures that each resident receives care 
and services for the provision of hemodialysis and/or peritoneal dialysis consistent with 
professional standards of practice including the: 
 
• Ongoing assessment of the resident’s condition and monitoring for complications 
before and after dialysis treatments received at a certified dialysis facility; 
 
• Safe administration of hemodialysis at the bedside and/or peritoneal dialysis in 
the nursing home provided by qualified trained staff/caregivers, in accordance 
with State and Federal laws and regulations; 
 
• Ongoing assessment and oversight of the resident before, during and after dialysis 
treatments, including monitoring the resident’s condition during treatments, 

monitoring for complications, implementing appropriate interventions, and using 
appropriate infection control practices; and 
 
• Ongoing communication and collaboration with the dialysis facility regarding 
dialysis care and services. 
 
DEFINITIONS: §483.25(l) 
 
“End-Stage Renal Disease (ESRD)” - The stage of renal impairment that appears 
irreversible and permanent, and requires a regular course of dialysis or kidney 
transplantation to maintain life. (42 CFR, Part §405 - §405.2102) 
 
“Dialysis” - A process by which dissolved substances are removed from a patient’s body 
by diffusion from one fluid compartment to another across a semipermeable membrane. 
The two types of dialysis that are currently in common use are hemodialysis (HD) and 
peritoneal dialysis (PD). (§405.2102) 
 
“Dialysis facility” - means an entity that provides outpatient maintenance dialysis 
services or home dialysis training and support services, or both. (§494.10 Definitions) 
 
“Home Dialysis” - 
Home dialysis means dialysis performed at home by an ESRD patient or 
caregiver who has completed an appropriate course of training as described in §494.100(a) of 
this part. 
 
NOTE: For the purposes of this guidance the term “nursing home” refers to a long-term 
care facility and dialysis facility refers to a Medicare certified dialysis facility. Home 
hemodialysis will be referenced as HHD. 
 
INTERPRETIVE GUIDANCE: §483.25(l) 
 
There is no requirement that a nursing home must offer dialysis services. If the nursing 
home has an arrangement with a dialysis facility for the provision of dialysis services, the 
nursing home must inform each resident before or at the time of admission, and 
periodically thereafter during the resident’s stay, of dialysis services, if available in the 
nursing home. 
 
Residents of a nursing home may receive dialysis treatments through two main options: 
 
• Medicare Certified Dialysis Facility: This may involve either: 
o Transporting to and from an off-site certified dialysis facility for dialysis 
treatments; or 
 
o Transporting to a location within or proximate to the nursing home building 
which is dedicated for and separately certified as a dialysis facility providing 
in-center dialysis; and/or 

• Dialysis in a Nursing Home: Receive home hemodialysis (HHD) or peritoneal 
dialysis (PD) treatments in the nursing home, by trained and qualified staff who 
have received training and competency from the dialysis facility. 
 
If a current resident has been identified as meeting the criteria for HHD/PD by the 
dialysis facility team, and the nephrologist or the physician prescribing dialysis, and 
chooses to receive either HHD/PD, and the nursing home does not allow for these onsite 
services, the nursing home must assist the resident with the transfer to a nursing home or 
in the relocation to a setting (e.g. private home, or residential/assisted living facility) of 
his/her choice that provides HHD/PD services. 
 
NOTE: The long-term care survey team does not have the authority under Federal 
nursing home regulations to review the care and services provided directly within a 
Medicare-certified dialysis facility located either on or offsite. If at any time during the 
survey, a concern or issue arises regarding the dialysis services provided to a sampled 
resident by the dialysis facility, the survey team should report this as a complaint to the 
State Agency survey unit responsible for oversight of the Medicare certified ESRD 
entity. The survey team must identify the specific resident(s) involved and the concerns 
identified. 
 
Responsibilities for the Provision of Dialysis Care/Services 
 
If the nursing home has made the decision to provide dialysis care and services according 
to the options above, there must be, in accordance with current standards of practice, 
coordination and collaboration between the nursing home and the dialysis facility to 
assure that: 
 
• The resident’s needs related to dialysis treatments are met; 
 
• Only trained and qualified staff/caregivers administer the dialysis treatments; 
 
• The provision of the dialysis treatments and care of the resident meets current 
standards of practice for the safe administration of the dialysis treatments; 
 
• Documentation requirements are met to assure that treatments are provided as 
ordered by the nephrologist, attending practitioner and dialysis team; and 
 
• There is ongoing communication and collaboration for the development and 
implementation of the dialysis care plan by nursing home and dialysis staff. 
 
The nursing home remains responsible for the overall quality of care the resident receives 
and must provide the same services to a resident who is receiving dialysis as it furnishes 
to its residents who are not. This includes the ongoing provision of assessment, care 
planning and provision of care. There must be a coordinated plan for dialysis treatments 
developed with input from both the nursing home and dialysis facility. The resident 
should not experience any lack of nursing home services or care because of his or her 

dialysis status. The nursing home staff must be aware and identify changes in resident’s 
behavior, especially for a cognitively impaired resident, that may impact the safe 
administration of dialysis, including, resistance to care, and pulling on tubes/access sites 
and inform the attending practitioner and dialysis facility of the changes. This requires 
more frequent and increased observations and monitoring for this resident before, during 
(if dialysis is provided by nursing home staff/caregivers or the resident) and after dialysis 
treatments. 
 
NOTE: The nursing home may wish to designate a staff person to coordinate activities 
and communications with each dialysis facility that they have arrangements with to 
provide dialysis services. 
 
The dialysis facility is responsible for the medical management for the end stage renal 
disease including dialysis treatments, performed offsite or onsite. It is the responsibility 
of the dialysis facility to provide all necessary equipment and supplies for the provision 
of the dialysis treatments, including maintenance and repair as needed, testing/monitoring 
water and dialysate quality for the dialysis treatment, and for the training of individuals 
providing the HHD/PD. 
 
Shared Communication between the Nursing Home and the Dialysis facility 
It is essential that a communication process be established between the nursing home and 
the dialysis facility to be used 24-hours a day. The care of the resident receiving dialysis 
services must reflect ongoing communication, coordination and collaboration between 
the nursing home and the dialysis staff. The communication process should include how 
the communication will occur, who is responsible for communicating, and where the 
communication and responses will be documented in the medical record, including but 
not limited to: 
 
• Timely medication administration (initiated, administered, held or discontinued) 
by the nursing home and/or dialysis facility; 
Physician/treatment orders, laboratory values, and vital signs; 
 
• Advance Directives and code status; specific directives about treatment choices; 
and any changes or need for further discussion with the resident/representative, 
and practitioners; 
 
• Nutritional/fluid management including documentation of weights, resident 
compliance with food/fluid restrictions or the provision of meals before, during 
and/or after dialysis and monitoring intake and output measurements as ordered; 
 
• Dialysis treatment provided and resident’s response, including declines in 
functional status, falls, the identification of symptoms such as anxiety, depression, 
confusion, and/or behavioral symptoms that interfere with treatments; 

• Dialysis adverse reactions/complications and/or recommendations for follow up 
observations and monitoring, and/or concerns related to the vascular access 
site/PD catheter; 
 
• Changes and/or decline in condition unrelated to dialysis. This would include 
communication related to care concerns such as a resident who is at risk for or 
who has a pressure ulcer, receiving appropriate interventions; and 
 
• The occurrence or risk of falls and any concerns related to transportation to and 
from the dialysis facility. 
 
Coordination of Physician Services between the Nursing Home and Dialysis facility 
 
For a resident receiving dialysis, the nursing home staff must immediately contact and 
communicate with the attending physician/practitioner, resident/resident representative, 
and designated dialysis staff (i.e., nephrologist, registered nurse) regarding any 
significant changes in the resident’s status related to clinical complications or emergent 
situations that may impact the dialysis portion of the care plan. (Refer to F580 – 
Notification of Changes in condition) These situations may include but are not limited to 
changes in cognition or sudden unexpected decline in condition, dialysis complications 
such as bleeding, hypotension, or adverse consequences to a medication or therapy, or 
other situations. 
 
Any changes in the resident’s care initiated by the dialysis facility must be communicated 
to the resident’s nursing home attending physician/practitioner. 
 
Hospital Transfer 
 
The dialysis facility must ensure access to a hospital for emergency services that has the 
capacity to provide emergency dialysis care (ESRD Conditions for Coverage (CfC) at 
V770 - §494.180). In order to assure that the dialysis needs of the resident are met in the 
case of an emergency, the care plan should identify acute care settings that would be able 
to meet the resident’s need for dialysis. 
 
In case of the need to transfer to an acute care facility to manage dialysis complications 
or other care concerns, the nursing home must have ongoing communication with the 
dialysis facility and have knowledge of the location and how to access the hospital that 
has the capacity to provide emergency dialysis care, as identified by the dialysis facility. 
 
NOTE: According to the ESRD regulations at V770 - §494.180 - The dialysis facility 
must have an agreement with a hospital that can provide inpatient care, routine and 
emergency dialysis and other hospital services, and emergency medical care which is 
available 24 hours a day, 7 days a week. The agreement must: (i) Ensure that hospital 
services are available promptly to the dialysis facility’s patients when needed. (ii) Include 
reasonable assurances that patients from the dialysis facility are accepted and treated in 
emergencies. 

Resident Care Policies and Staffing Specific to Dialysis Care and Services 
 
Some State licensure rules don’t allow for the provision of HHD in a nursing home 
and/or a State’s nurse practice act or scope of practice may preclude certain health care 
workers from performing HHD treatments. Some State licensing rules may have specific 
regulations related to the provision of HHD/PD in a nursing home, such as specifying 
patient to staff ratio requirements. The nursing home must identify who is allowed to 
provide HHD/PD treatments to a resident, such as a licensed nurse or nurse aide. The 
dialysis facility is responsible for providing training and assuring the competency of staff 
or individuals that are allowed to initiate, access and discontinue dialysis treatments. 
The nursing home must maintain documentation of completion of training/competency 
for staff or other individuals providing the dialysis treatments. 
 
NOTE: Anecdotally, it has been reported that some nursing homes provide dialysis for 
multiple residents at a time in a single area/den setting. The facility must assure that 
compliance is maintained for providing dialysis in a location that promotes dignity, 
individual privacy during treatments, sufficient staff, access to a call system and hand 
washing facilities, availability of emergency equipment and supplies, secured medication 
storage and preparation area, including a refrigerator as necessary, soiled utility area, 
disposal of equipment and supplies, and based upon professional standards of practice, 
the maintenance of effective infection control practices and measures. This includes 
ensuring that a resident who is hepatitis B+ is not dialyzed in the same location as 
resident who is not hepatitis B+. Consideration should be given to implementing 
appropriate infection control practices related to care of a resident who is hepatitis B+, 
such as using dedicated staff, a dedicated machine, equipment, instruments, and supplies 
that will not be used by other resident’s including a resident who is not hepatitis B+. 
 
If PD treatments are provided, the treatments may only be administered by an individual 
trained by the qualified dialysis trainer from the certified dialysis facility. An LPN/LVN 
may administer the PD treatment if not in conflict with the States Nurse Practice 
Act/Scope of practice. 
 
A nursing home, that provides dialysis treatments, in collaboration with the nursing home 
medical director and the dialysis facility, must develop dialysis specific 
policies/procedures, based upon current standards of practice. This includes the care of a 
resident receiving dialysis services whether in the facility or at an offsite location. (Refer 
to F841 – Responsibilities of Medical Director.) At a minimum, these policies must 
include, but are not limited to the following: 
 
• The identification of all staff or contracted individuals who are allowed to provide 
HHD/PD and the training required. An RN, LPN/LVN, a nurse aide or a trained 
technician can provide dialysis treatments if not in conflict with the States Nurse 
Practice Act/Scope of practice and only if the individual has received training 
from a qualified dialysis trainer from a certified dialysis facility for the individual 
resident receiving HHD/PD; 

• The documentation of training and competency requirements for individuals 
providing dialysis treatments; 
 
• If the facility allows a resident/family member or other individual to provide 
HHD or PD treatments, documentation that training and competency was 
provided by the certified dialysis facility; 
 
• Procedures for the initiation, administration and discontinuation of HHD/PD 
treatments, type of monitoring required before, during and after the treatments, 
including documentation requirements; 
 
• Procedures for methods of communication between the nursing home and the 
dialysis facility including how it will occur, with whom, and where the 
communication and responses will be documented; 
 
• The development and implementation of a coordinated comprehensive care 
plan(s) that identifies nursing home and dialysis responsibilities and provides 
direction for nursing home staff; and 
• The development and implementation of interventions, based upon current 
standards of practice including, but not limited to documentation and monitoring 
of complications, pre-and post-dialysis weights, access sites, nutrition and 
hydration, lab tests, vital signs including blood pressure and medications; 
 
• Management of dialysis emergencies including procedures for medical 
complications, and for equipment and supplies necessary; 
 
• The provision of medications on dialysis treatment days; 
 
• Procedures for monitoring and documenting nutrition/hydration needs, including 
the provision of meals on days that dialysis treatments are provided; 
 
• Assessing, observing and documenting care of access sites, as applicable, such as: 
 
o Auscultation/palpation of the AV fistula (pulse, bruit and thrill) to assure 
adequate blood flow; 
 
o Significant changes in the extremity when compared to the opposite extremity 
(edema, pain, redness); 
 
o Steal Syndrome (pain, numbness, discoloration, or cold to touch in the fingers 
or hand indicating inadequate arterial flow); 
 
o Skin integrity (waxy skin, ulcerations, drainage from incisions); 
o Bruising/hematoma; 

o Collateral vein distension (veins in access arm close to AV fistula becoming 
larger); 
 
o Complaints of pain or numbness; or 
 
o Evidence of infection at the surgical site, such as drainage, redness, tenderness 
at incision site, fever. 
 
• Safe and sanitary care and storage of dialysis equipment and supplies; 
 
• Responsibility for reporting adverse events, including who to report to, 
investigating the event and correcting identified problems; 
 
• Response and management of technical problems related to HHD and/or PD 
treatments, such as power outages or: 
 
o For PD, how to recognize impaired flow and drainage or failure of the PD 
cycler; 
 
o For failure of HHD machines: clotting of the hemodialysis circuit, dialyzer 
blood leak, or line disconnection; and 
 
o For HHD/PD: how and when to stop dialysis and/or seek help when there are 
significant issues. 
 
NOTE: The dialysis facility is responsible for the overall provision and maintenance of 
the dialysis equipment and monitoring source water. The nursing home staff should be 
aware of any issues with the source water, and the care plan should address these issues. 
The nursing home trained and qualified staff responsible for providing the dialysis 
treatment, must know how to use the dialysis equipment and identify if there are issues in 
order to provide safe treatments. 
 
• Dialysis specific infection control policies, including but not limited to: 
 
o Transmission based precautions including blood borne precautions, 
placement/location (cohorting), staff/visitor personal protection equipment 
(PPE) requirements, indications for the use of gloves, masks, and hand 
hygiene; 
 
o Potential health care associated infections (HAI) including Hepatitis B and 
tuberculosis; 
 
o Restrictions for visitors/roommate, if any, during provision of HHD/PD; 

o Handling, using, and disposing of equipment/supplies, medications or other 
products in accordance with manufacturer’s instructions, and in accordance 
with all applicable Federal, State and local laws and regulations; 
 
NOTE: Nursing home staff who have been trained to provide dialysis treatments for a 
resident, must understand how to properly dispose of needles, effluents, disposable items, 
blood tubing and dialyzers to minimize risks of infection or injury to self and others and 
to prevent environmental contamination (e.g. using impervious puncture resistant 
containers for disposal of sharps, placing empty dialysate bags and dialysis tubing and 
other contaminated items in specific biohazard container(s) or bag(s) before discarding. 
 
o Obtaining and reviewing dialysis facility monitoring for the dialysis water and 
dialysate quality, including total chlorine testing and at least quarterly testing 
of water and dialysate bacterial and endotoxin as applicable to the HHD 
equipment in use; 
 
o Types of furnishings allowed (such as a recliner used during the dialysis 
treatment), based on infection control standards and the cleaning/sanitizing of 
these furnishings that have the potential to become contaminated with 
blood/blood products; 
o Access to clean sink for hand washing, in addition, disposal needs to be 
addressed for dialysis by-products from the dialysis treatment; 
 
o Housekeeping/laundry policies for cleaning/sanitizing the location(s) where 
treatments are provided, including linen handling and waste disposal; 
 
o Vascular access or peritoneal catheter care and dressing changes; and 
 
o Cleaning and disinfecting dialysis equipment, including procedures for spills 
and splashes of blood or effluent on furnishings, equipment, floors and 
supplies. 
 
NOTE: For information regarding home dialysis guidance see ESRD CFR §494.100 – 
V580 Care at Home. This condition also provides information regarding the provision of 
home dialysis including water treatment and quality testing and other requirements of the 
ANSI/AAMI RD52:2004. For information related more specifically to water testing and 
treatment refer to: 
 
• V-253 -ANSI/AAMI RD52:2004 Requirements as Adopted by Reference 42 CFR 
§494.40 (a)7.2 Microbial monitoring methods: 7.2.1 General: Dialysate: monthly 
dialysate sample/collection/frequency. Culture …dialysate fluid weekly for new 
systems until a pattern has been established. For established systems, culture 
monthly unless a greater frequency is dictated by historical data at a given 
institution; and 

• V 278 - In-center preconfigured HD: quarterly cultures/LALs Moreover, the 
facility must perform bacteriological and endotoxin testing on a quarterly, or more 
frequent basis, as needed, to ensure that the water and dialysate are within AAMI 
limits. 
 
Some portable dialysis machines may have a self-check system and more stringent 
requirements may need to be followed as recommended by the manufacturer. 
 
Dialysis Provided at a Medicare Certified Dialysis Facility Located Offsite or Onsite 
 
A resident may choose to receive dialysis at a dialysis facility located off site or in a 
separately certified dialysis unit located within the facility. The choice of the dialysis 
provider is made by the resident/resident representative. The nursing home must assist 
the resident to assure that arrangements are provided for safe transportation to and from 
the dialysis facility. (See F745 – Social Services). 
 
The nursing home staff must provide immediate monitoring and documentation of the 
status of the resident’s access site(s) upon return from the dialysis treatment to observe 
for bleeding or other complications. The nursing home and dialysis facility dietitians 
should coordinate the nutritional care including monitoring, documenting, and deciding 
how and when to address weight changes and nutrition issues. This includes identifying 
weight fluctuations due to fluid retention between dialysis sessions, possible fluid volume 
depletion in the immediate post-dialysis period or associated with anorexia which may be 
due to renal failure. Staff must weigh the resident and document the findings based on 
orders. If weight loss occurs, the facility must notify the attending practitioner and 
dialysis facility practitioner regarding the management for causes of anorexia and weight 
loss other than fluid loss that might present. 
 
Home Hemodialysis provided by Nursing Home Staff 
 
The nursing home must continue to meet the nursing home requirements found 
throughout 42 CFR Part §483 to assure the residents health, safety and well-being. The 
facility must be able to demonstrate in collaboration with the dialysis facility, the 
arrangements in place in order to provide safe HHD/HPD through qualified trained 
staff/caregivers and assure that the resident receives the dialysis treatments as ordered. 
The nursing home is responsible for the ongoing coordination of dialysis care in 
collaboration with the Medicare certified ESRD entity. The nursing home resident who 
receives dialysis is entitled to the same rights, services, and efforts to achieve expected 
outcomes as a person receiving dialysis at a dialysis facility. 
 
NOTE: According to 42 CFR §494.100 - V581, a dialysis facility that is certified to 
provide services to home patients must ensure through its interdisciplinary team, that 
home dialysis services are at least equivalent to those provided to in-facility patients and 
meet all applicable conditions part 494. This does not imply that the nursing home 
surveyor surveys to or applies ESRD regulations. 

• Provision of HHD Treatments 
 
The nursing home and the dialysis facility must have ongoing communication to 
coordinate the care and manage any changes/issues that arise. The nursing home staff 
must use appropriate infection precautions, including blood-borne precautions, for all 
aspects of dialysis care. In addition, if the HHD is provided in a semi-private resident 
room, adherence to the right of privacy during treatment is required. The nursing home 
staff must have specific written guidance for identifying and handling complications and 
emergencies before, during and after the provision of HHD. 
 
The nursing home must have a system in place for staff to contact the dialysis facility 
immediately with any concerns/issues regarding dialysis. This includes who to 
communicate with, such as the dialysis staff, attending practitioner, or nephrologist 
regarding HHD. The nursing home must have dialysis facility contact numbers readily 
accessible to licensed nursing home staff that assures the on-call dialysis qualified 
licensed professional staff is available by phone 24 hours a day 7 days a week. 
 
HHD may be performed by either the resident (if physically and cognitively capable) or 
an individual, such as a family member (if allowed by the nursing home), nursing home 
staff or a contracted individual, such as a licensed nurse or dialysis technician, who has 
completed training/competency by a qualified trainer from a Medicare certified dialysis 
facility in accordance with State licensure, Scope of Practice for Nursing. The required 
training for staff providing HHD (and PD) treatments in nursing homes must be 
individualized and resident specific and provided directly by the Medicare certified 
dialysis facility that is responsible for the provision of the resident’s overall dialysis care. 
This training cannot be provided by nursing home staff even if they have previously 
received the training for dialysis by this or another dialysis facility for another resident. 
The nursing home must have documentation of the completion of resident specific 
dialysis training by the dialysis facility for each nursing home staff member providing 
dialysis treatments for the resident. While a nursing home may allow a resident and/or a 
dialysis trained caregiver to provide the dialysis treatment, the nursing home nonetheless 
remains responsible for the resident’s care and services. 
 
The facility must maintain documentation of the required ongoing dialysis training in 
order to assure qualified staff/caregivers are capable of providing the HHD treatments. 
(Refer to F658) Training based upon current standards of practice must include, but not 
be limited to, the following: 
 
• Specific (step-by step) instructions on how to use the resident’s prescribed 
dialysis equipment (e.g. hemodialysis machine and water treatment components); 
 
• Specific (step-by step) instructions in home dialysis procedures to facilitate 
adequate dialysis as prescribed by the physician; 
 
• Training in proper storage and administration of Erythropoiesis-Stimulating 
Agents (ESAs), if applicable and in accordance with State laws and State scope of 

practice. ESAs are medications that may be used to treat anemia in a resident with 
a diagnosis of ESRD; 
 
• How to identify/recognize medical emergencies, implement immediate 
responses/actions and methods for contacting emergency medical systems. 
Medical emergencies may include, but are not limited to, cardiac arrest, air 
embolism, drug reactions, suspected pyrogen reactions, profound hypotension or 
hypertension and significant blood loss; 
 
• How to recognize, manage and report such potential complications as vascular 
access problems such as difficulty with cannulation, a change in bruit or thrill, or 
bleeding, and infections, hypertension or hypotension, hyperkalemia, etc; 
 
• Infection control practices, including indications for the use of gloves, masks, and 
other personal protective equipment, methods for hand hygiene, vascular access 
and dressing changes, cleaning and disinfecting dialysis equipment, cleaning and 
disinfection procedures for spills and splashes of blood or effluent; 
 
• Identifying symptoms associated with water and dialysate contamination that 
cannot be readily attributed to other causes. Clinical symptoms may include, but 
are not limited to, chills, shaking, fever, vomiting, headache, dizziness, muscle 
weakness, skin flushing, itching, diarrhea, hyper/hypotension, hemolysis and 
anemia. If such symptoms are present, the facility must notify the attending 
practitioner and dialysis team to determine appropriate action; and 
 
• Recognizing, managing and reporting power outages, failure of the HD machine, 
failure of water treatment components (e.g., chlorine/chloramine breakthrough), 
clotting of the hemodialysis circuit, dialyzer blood leaks, line disconnection, 
water supply problems or leaks, and problems with supply delivery. 
 
The nursing home must have orders for the provision of the dialysis treatments, including 
individualized dialysis prescription such as, at a minimum, the number of treatments per 
week, length of treatment time, the type of dialyzer, and specific parameters of the 
dialysis delivery system (e.g., electrolyte composition of the dialysate, blood flow rate, 
and dialysate flow rate), anticoagulation, and the resident’s target weight. 
 
The resident’s care plan must, based on standards of practice, identify the resident 
specific parameters for blood pressure, weights and other vital signs. The resident’s 
blood pressures must be monitored pre, during, and post treatment and abnormal values 
must be addressed. Excessively high or low blood pressure measurements during 
treatment without evidence of assessment and action to address those values would 
indicate the care plan for this parameter was either not developed or not implemented. 
The nursing home staff must provide ongoing assessment of the resident during dialysis, 
including vital signs, level of consciousness, muscle cramping, itching and comfort or 
distress; and must report identified or suspected complications to the attending 
practitioner and identified dialysis staff to enable timely interventions. In addition, staff 

must ensure that a resident who is hepatitis B+ is not dialyzed in the same location as 
resident who is not hepatitis B+. Consideration should be given to implementing 
appropriate infection control practices related to care of a resident who is hepatitis B+, 
such as using dedicated staff, a dedicated machine, equipment, instruments, and supplies 
that will not be used by other resident’s including a resident who is not hepatitis B+. 
 
NOTE: According to the interpretive guidelines at ESRD regulation V581 - CFR 
§494.100 Condition: Care at Home – “Home dialysis patients are considered part of the 
census of the ESRD facility and are entitled to the same rights, services, and efforts to 
achieve expected patient outcomes as the in-center dialysis patients of the facility.” 
 
After receiving dialysis, staff must obtain vital signs, assess the resident’s stability and 
monitor for post-dialysis complications and symptoms such as but not limited to 
dizziness, nausea, vomiting, fatigue or hypotension. 
 
The resident receiving HHD must be under direct observation of the trained caregiver 
who must be physically present in the room with the resident throughout the entire HHD 
treatment in the immediate location where the HHD is being provided. 
 
NOTE: Nursing home staff assigned to provide an HHD treatment, must not have 
assignments for additional residents throughout the duration of the HHD treatment and 
after completed until the resident is determined stable according to accepted standards of 
practice. 
 
The resident’s vascular access site and bloodline connections must be able to be seen by 
the trained caregiver throughout the dialysis treatment. Allowing a resident to cover 
access sites and line connections provides an opportunity for accidental needle 
dislodgement or a line disconnection to go undetected. This dislodgement or 
disconnection could result in exsanguination and death in minutes. The medical record 
should reflect the care and monitoring of the access site, including but not limited to 
examining the arteriovenous fistula (AV fistula) and/or surgical incisions to detect 
problems that require immediate notification of the attending practitioner. 
 
Peritoneal Dialysis (PD) Provided by Nursing Home Staff 
 
If the nursing home provides PD on site, it is responsible for the ongoing coordination of 
dialysis care in collaboration with the Medicare certified dialysis facility. The nursing 
home staff must have specific written guidance for the provision of treatments, and 
handling complications and emergencies during the provision of PD. The nursing home 
must have contact information available for staff to assure that dialysis qualified licensed 
professional staff is available by phone 24 hours a day 7 days a week, including who to 
communicate with regarding PD related issues. 
 
PD may be performed by either the resident (if physically and cognitively capable) or an 
individual, such as a family member (if allowed by the nursing home), nursing home staff 
or a contracted caregiver who has completed training/competency by a qualified trainer 

from a Medicare certified dialysis facility. While a nursing home may allow a resident 
and/or a dialysis trained caregiver to provide the dialysis treatment, the nursing home 
nonetheless remains responsible for the resident’s care and services. 
 
The facility must maintain documentation of the required ongoing dialysis training in 
order to assure qualified staff/caregivers are capable of providing the PD treatments. 
(Refer to F658 – Meeting professional standards) Training based upon current standards 
of practice must include, but not be limited to, the following: 
 
• Specific (step-by step) instructions on how to use the resident’s prescribed 
dialysis equipment (e.g. peritoneal dialysis cycler) and instructions in home 
dialysis procedures for PD to facilitate adequate dialysis as prescribed by the 
practitioner; 
 
• Training in proper storage and administration of Erythropoiesis-Stimulating 
Agents (ESAs), if applicable; 
 
• How to identify/recognize medical emergencies, implement immediate 
responses/actions and methods for contacting emergency medical systems. 
Medical emergencies may include, but are not limited to, cardiac arrest, drug 
reactions, suspected pyrogen reactions, profound hypotension or hypertension and 
significant blood loss; 
 
• How to recognize, manage and report dialysis complications, including catheter, 
tunnel or exit site infection; peritonitis; catheter dislodgement; hypotension; 
hypokalemia; failure of sufficient dialysate to drain from the peritoneal space; 
protein malnutrition; 
 
• Indications for the use of gloves, masks, and other personal protective equipment, 
methods for hand hygiene, peritoneal catheter care and dressing changes, cleaning 
and disinfecting dialysis equipment, cleaning and disinfection procedures for 
spills and splashes of effluent; 
 
• How to properly dispose of needles, effluents, disposable items, and tubing and to 
minimize risks of infection or injury to self and others and to prevent 
environmental contamination (e.g. using impervious puncture resistant containers 
for disposal of sharps, placing empty dialysate bags and tubing in intact plastic 
bags before discarding.); and 
 
• Recognizing, managing and reporting power outages, failure of the PD cycler. 
 
Provision of PD Treatment 
 
PD may be provided via the following modalities: 

• Continuous ambulatory peritoneal dialysis (CAPD) is a treatment in which 
dialysis solution is introduced through a catheter into the abdomen via gravity and 
the bag is disconnected. After a specified period of time, the catheter is 
reconnected and drains the solution containing wastes back into the bag. CAPD 
does not require a machine; the process uses gravity to fill and empty the 
abdomen. CAPD may be provided during three or four exchanges during the day 
and one overnight. A mini-cycler machine may be used to exchange the dialysis 
solution overnight as the resident sleeps; or 
 
• Continuous cycler-assisted peritoneal dialysis (CCPD) uses a machine to fill 
and empty the abdomen three to five times during the night. In the morning, the 
last fill remains in the abdomen with a dwell time that is individualized according 
to the resident’s needs. In some cases, an additional exchange is done in the mid-
afternoon to increase the amount of waste removed and to prevent excess fluid 
absorption. 
 
For a resident receiving PD, the practitioner orders for the individualized prescription 
must include at least the number of exchanges or cycles to be done during each dialysis 
session, the volume of fluid with each exchange, duration of fluid in the peritoneal cavity, 
the concentration of glucose or other osmotic agent to be used for fluid removal, and the 
use of an automated, manual, or combined techniques. 
 
Before, during and after receiving the PD, nursing home staff must, based on 
practitioner’s orders and professional standards of practice, obtain vital signs, weights, 
assess the resident’s stability level of consciousness, and comfort or distress; and monitor 
for post-dialysis complications and symptoms such as but not limited to dizziness, 
nausea, fatigue or hypotension. The staff must report identified or suspected 
complications immediately to the attending practitioner and dialysis staff to enable timely 
interventions. The resident’s record must include documentation of ongoing evaluation 
of the peritoneal catheter, including assessment of catheter related infections (For 
example, exit site acute and chronic infections) and tunnel for condition, monitoring for 
patency, leaks, infection, and bleeding at the site. In addition, staff should be monitoring 
for complications such as peritonitis (For example, abdominal pain/tenderness/distention, 
cloudy PD fluid, fever, nausea and vomiting). 
 
NOTE: For more information related to PD related infections, refer to 
https://www.cdc.gov/disasters/icfordialysis.html

Interim and Emergency Medications for Residents Receiving Dialysis 
 
Nursing homes must have access to medications and treatments such as antibiotics and 
intravenous fluids to treat common complications of dialysis. The nursing home staff 
must collaborate with the medical director, consultant pharmacist and dialysis facility to 
develop policies and procedures to address common complications and to ensure access 
to needed medications. 

The attending practitioner and dialysis team may have prescribed Erythropoiesis-
Stimulating Agents (ESAs), which are medications that may be used to treat anemia in a 
resident with a diagnosis of ESRD. These medications act similarly to erythropoietin to 
stimulate the production of red blood cells and are administered either intravenously or 
subcutaneously. Commonly used ESAs include Epogen (epoetin alfa) 2 and Aranesp 
(darbepoetin alfa). Other causes of anemia unrelated to kidney disease (e.g., hemolytic 
anemia and blood loss anemia) may also occur in individuals with ESRD. Additionally, 
many anemic individuals with ESRD are also treated with iron supplements because iron 
is necessary for the production of red blood cells. These include iron supplements such as 
Venofer (iron sucrose) and Ferrlecit (sodium ferric gluconate complex) to treat iron-
deficiency anemia. 
 
NOTE: ESAs were approved by the FDA starting with Epogen for the treatment of 
anemia in 1989 and Aranesp in 2001. Since the approval, the product labeling for this 
class of medications has been updated several times to incorporate new safety 
information. The FDA approved-new labeling for both drugs in March 2007 that 
included a warning that ESAs can increase the risk for death and serious cardiovascular 
events (including myocardial infarction, stroke, heart failure) when they are dosed to 
achieve a target hemoglobin of greater than 12 g/dL. For individuals with chronic kidney 
disease on dialysis, FDA approved labels for ESAs now recommend that health care 
professionals initiate ESA treatment when the hemoglobin level is less than 10 g/dL and 
that the dose be reduced or interrupted if the hemoglobin approaches or exceeds 11 g/dL,. 
Ongoing monitoring is mandated to ensure efficacy as well as safety and reimbursement 
of the medication(s). 
http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandpro
viders/ucm109375.htm 
 
Depending on the dialysis method and the resident’s comorbidities, medication 
administration may need to be modified. The attending practitioner and nephrologist 
determine which medications are to be administered during dialysis, which are to be held 
prior to dialysis (e.g., because of excessive hypotension during dialysis), whether any 
specific medications are to be given prior to dialysis and any medications (such as 
antibiotics or ESA’s) that are to be given by dialysis staff. All such medication 
administration must be coordinated, communicated and documented between dialysis 
staff, nursing home staff, and practitioners. (For issues related to medications and or 
pharmacy review, refer to F757 Unnecessary Medications, and/or F755 Pharmacy 
Services and/or F756 – Pharmacy Review.) 
 
Canceling or Postponing Dialysis (Either HD, HHD and/or PD) 
 
The nephrologist/dialysis team, the resident’s attending practitioner must be notified of 
the canceled or postponed dialysis treatment and responses to the change in treatment 
must be documented in the resident’s medical record. If dialysis is canceled or 
postponed, the nursing home and dialysis staff should provide or obtain ongoing 
monitoring and medical management for changes such as fluid gain, respiratory issues, 

review of relevant lab results, and any other complications that occur until dialysis can be 
rescheduled based on resident assessment, stability and need. 
 
• Lack of sufficient trained and qualified staff to provide treatments 
 
 In the event circumstance do not allow dialysis to be provided by the designated 
trained and qualified individual, the nursing home must immediately notify the 
dialysis facility in order to make arrangements to assure that no dialysis 
treatments are missed. 
 
• Equipment Failure for HHD/PD 
 
 Dialysis may be stopped, postponed, or delayed due to dialysis equipment failure. 
If this happens during dialysis, the staff and practitioner must assess the resident 
immediately to assure that urgent medical needs are met, identify and manage any 
consequences, contact the dialysis facility and reschedule the dialysis as 
appropriate and/or transport the resident to the off-site certified dialysis facility to 
receive the required dialysis treatments. The staff must check the equipment and 
supplies to identify what happened, and why, and arrange with the dialysis facility 
for the repair/replace the equipment and supplies as necessary. 
 
• Resident Declines or Acute Illness, Or Resident Complications 
 
 Dialysis may be stopped, postponed or delayed due to a resident’s declines of the 
dialysis treatment or the presence of acute illness or complications to the resident 
before, during, after, and in between dialysis sessions. As part of care 
coordination between the nursing home and the dialysis facility, there must be a 
systematic approach to handling situations where the resident has a condition 
change and/or becomes ill or unstable during dialysis. This approach includes 
knowing who is to be contacted, who decides whether to stop dialysis, who 
documents the situation, under what circumstances dialysis may be terminated 
and when the dialysis treatment may be restarted or the next treatment scheduled. 
The record must reflect the how the missed treatments will be addressed in order 
to prevent an avoidable decline and/or potential complications. If a resident 
wants to decline the dialysis treatment(s), the nursing home and dialysis facility 
social workers, should coordinate services to assess psychosocial concerns related 
to the resident’s desire to discontinue dialysis treatments. 
 
The nursing home and dialysis staff must coordinate their approaches in order to provide 
immediate care for possible emergencies and complications, such as cardiac arrest during 
dialysis. Any orders related to cardio-pulmonary resuscitation (CPR) and any documents 
that might be needed (e.g., practitioner orders for life-sustaining treatment, advance 
directives including code status) must be available for both the nursing home and the 
dialysis staff. Knowledge of existing advance directives, including specific directives 
about treatment choices and code status, must be communicated between dialysis and 

nursing home staff to ensure that there is a uniform approach, consistent with State laws 
and regulations. (Refer to F678 – Advance Directives) 
 
ADMINISTRATIVE REVIEW OF NURSING HOME PRACTICES 
 
As appropriate, the administrator, nursing director, medical director, and pharmacist, and 
the QAA committee should review the nursing home’s dialysis care and services on an 
ongoing basis including: 
 
• The communication, training, supervision and care coordination between the 
nursing home and the participating dialysis facility; 
 
• Whether policies and procedures for the types of dialysis that are provided in the 
nursing home are consistent with current standards of practice and are being 
followed consistently; 
 
• Any complications associated with dialysis provision, such as those 
associated 
with potential breeches in infection control, those resulting in hospitalization and 
those due to equipment, technique, process failures, or supplies; 
 
• Provision of ongoing staff training which is individualized to meet the needs of 
each HHD/PD resident. Staff training must be provided by qualified dialysis 
facility instructors and include how to address emergencies; and 
• Communication and coordination between the nursing home and the dialysis 
facility in sharing data about outcomes and processes and reviewing quality 
indicators and care issues. 
 
Investigative Summary for Dialysis Care and Services 
 
Use 
 
Use the Dialysis Critical Element (CE) Pathway, along with the interpretive guidelines 
when determining if the facility meets the requirements for providing care and services 
for a resident receiving dialysis services, in accordance with professional standards of 
practice, and the comprehensive person-centered care plan, 
 
Summary of Investigative Procedure 
 
Briefly review the most recent comprehensive assessments, comprehensive care plan and 
orders to identify whether the facility has recognized, assessed, provided interventions 
and implemented care and services according to professional standards of practice in 
order to meet the resident’s dialysis care needs under investigation. This information will 
guide observations and interviews to be made in order to corroborate concerns identified. 
In addition, investigate to assure that there are sufficient numbers of trained, qualified 
and competent staff to provide the interventions identified for a resident receiving 
dialysis care and services. 

If the resident has been in the facility for less than 14 days (before completion of all the 
Resident Assessment Instrument (RAI) is required), review the baseline care plan which 
must be completed within 48 hours to determine if the facility is providing appropriate 
care and services based on information available at the time of admission. In addition, 
review to determine whether the comprehensive care plan is evaluated and revised based 
on the resident’s response to interventions. 
 
NOTE: Always observe for visual cues of psychosocial distress and consider whether 
psychosocial harm has occurred when determining severity level (See guidance on 
Severity and Scope Levels and Psychosocial Outcome Severity Guide located in the 
Survey Resources zip file located at 
https://www.cms.gov/medicare/provider-enrollment-
and-certification/guidanceforlawsandregulations/nursing-homes). In addition, if 
noncompliance at this tag demonstrates a pervasive disregard for the resident’s quality of 
life, consider investigating concerns at F675 – Quality of Life. 
 
OTHER TAGS, CARE AREAS (CA) AND TASKS TO CONSIDER: 
 
Dignity CA (F550); Right to be informed and make treatment decisions (F552); Right to 
refuse (F578); Advance Directives CA (F561); Notification of change (F580); 
Accommodation of needs, call system (Environment task & F558); Be provided by 
qualified persons (F659); Pressure ulcer CA (F686); Nutrition CA(F692); Hydration CA 
(F692); Sufficient and Competent Staffing (Task & F725); Unnecessary Medications CA 
(F757); Infection Control (Task & F880); Medical director (F841); Resident Records 
(F842); and QA&A QAPI (Task F868); 
 
DEFICIENCY CATEGORIZATION 
 
NOTE: The death or transfer of a resident, who was harmed as a result of nursing home 
practices, does not remove a finding of immediate jeopardy. The nursing home is 
required to implement specific actions to correct the deficient practices which allowed or 
caused the immediate jeopardy. 
 
Examples that demonstrate severity at Level 4 include, but are not limited to: 
 
• The nursing home failed to ensure that the nursing home staff provided adequate 
monitoring for a resident after returning from receiving an offsite HHD treatment 
at an ERSD unit. The resident was found to have pulled out the hemodialysis 
catheter and was found by staff over an hour later to be profusely bleeding which 
led to death. 
 
• The nursing home failed to ensure that nursing home staff providing the HHD 
monitored and identified complications during a dialysis treatment. The 
resident’s vital signs were not monitored during the dialysis treatment and as a 
result, the resident experienced serious hypotensive complications resulting in an 
emergency transfer and admission to the hospital. 

• The nursing home failed to ensure that the nursing home staff monitored the PD 
catheter site for complications. The nursing home staff providing the PD 
treatments, failed to monitor the condition of the PD catheter site and identify 
signs of infection. As a result of the infection at the catheter site, the resident 
required medical intervention for removal of the catheter and initiation of 
hemodialysis. 
 
Examples that demonstrate severity at Level 3 may include, but are not limited to: 
 
• The nursing home failed to notify the attending practitioner and dialysis team of 
changes in a resident’s behavior and failed to assure the treatments were provided 
according to the orders. A cognitively impaired resident was observed during a 
HHD treatment to exhibit combative and resistive behaviors, such as pulling at 
the tubing and access site. The resident had a history of previously dislodging the 
catheter, causing bleeding. The resident was observed trying to remove his/her 
shoes and trying to stand up from the dialysis chair and requires constant 
supervision during the treatment. The staff attributed the behavioral symptoms to 
dementia and administered a benzodiazepine to try to sedate the resident. Due to 
the behavioral symptoms, the HHD treatment had to be discontinued but the 
practitioner wasn’t contacted regarding discontinuing the treatment. This had 
occurred several times, however the nursing home staff failed to contact the 
practitioner, identify underlying causes, such as delirium or medication side 
effects and did not attempt to consider environmental or other non-
pharmacological measures to try to reduce the restlessness during dialysis. As a 
result of the treatments being discontinued early, the resident had electrolyte 
imbalance and fluid retention. 
 
Examples that demonstrate Severity Level 2 include, but are not limited to: 
 
• The nursing home failed to ensure that the nursing home staff provided PD 
treatments as ordered. The nursing home staff providing the PD failed to follow 
the orders for the duration of fluid in the peritoneal cavity however, the resident’s 
status was stable. 
 
• The nursing home failed to ensure that the nursing home staff provided PD 
treatments as ordered. The nursing home staff failed to identify a recent change 
in a resident’s dialysis order for an increase in the number of daily PD treatments; 
however, the resident’s status was stable. 
 
Severity Level 1: No actual harm with potential for minimal harm 
 
The failure of the nursing home to provide appropriate care and services to a resident 
who is receiving dialysis care and services is more than minimal harm. Therefore, 
Severity Level 1 does not apply for this regulatory requirement.